Russell Investments Group, Ltd. Intra Cellular Therapies, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 53,323 shares of ITCI stock, worth $4.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

53,323

Previous 69,738 23.54%

Holding current value

$4.62 Million

Previous $4.78 Million 18.38%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$67.99 - $80.84 $1.12 Million - $1.33 Million	-16,415 Reduced 23.54%	53,323 $3.9 Million
Q2 2024 Aug 08, 2024	BUY	$64.76 - $79.84 $1.22 Million - $1.51 Million	18,893 Added 37.16%	69,738 $4.78 Million
Q1 2024 May 08, 2024	BUY	$64.37 - $75.65 $2.29 Million - $2.69 Million	35,528 Added 231.95%	50,845 $3.52 Million
Q4 2023 Feb 05, 2024	BUY	$46.37 - $73.65 $351,113 - $557,677	7,572 Added 97.77%	15,317 $1.1 Million
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $416 - $512	-8 Reduced 0.1%	7,745 $403,000
Q2 2023 Aug 10, 2023	BUY	$54.67 - $66.44 $213,814 - $259,846	3,911 Added 101.8%	7,753 $490,000
Q1 2023 May 09, 2023	BUY	$43.8 - $56.99 $1,839 - $2,393	42 Added 1.11%	3,842 $208,000
Q3 2022 Nov 04, 2022	SELL	$42.7 - $59.99 $4.49 Million - $6.3 Million	-105,073 Reduced 96.51%	3,800 $176,000
Q2 2022 Jul 29, 2022	SELL	$43.0 - $65.64 $14.4 Million - $22 Million	-335,502 Reduced 75.5%	108,873 $6.21 Million
Q1 2022 May 05, 2022	BUY	$38.74 - $62.09 $2.39 Million - $3.83 Million	61,756 Added 16.14%	444,375 $27.2 Million
Q4 2021 Jan 21, 2022	SELL	$35.2 - $53.42 $558,624 - $847,775	-15,870 Reduced 3.98%	382,619 $20 Million
Q3 2021 Nov 08, 2021	BUY	$28.72 - $42.49 $3.62 Million - $5.36 Million	126,168 Added 46.33%	398,489 $14.9 Million
Q2 2021 Aug 04, 2021	BUY	$29.3 - $44.5 $7.7 Million - $11.7 Million	262,787 Added 2756.31%	272,321 $11.1 Million
Q1 2021 May 10, 2021	BUY	$30.8 - $39.51 $293,647 - $376,688	9,534 New	9,534 $323,000
Q4 2020 Feb 08, 2021	SELL	$23.34 - $32.22 $169,098 - $233,433	-7,245 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$14.35 - $26.64 $727,932 - $1.35 Million	-50,727 Reduced 87.5%	7,245 $185,000
Q4 2019 Jan 29, 2020	BUY	$7.26 - $38.49 $188,549 - $999,623	25,971 Added 81.16%	57,972 $1.99 Million
Q3 2019 Nov 01, 2019	BUY	$7.47 - $14.03 $106,828 - $200,643	14,301 Added 80.8%	32,001 $239,000
Q2 2019 Aug 09, 2019	BUY	$10.65 - $14.29 $70,290 - $94,314	6,600 Added 59.46%	17,700 $230,000
Q1 2019 May 13, 2019	BUY	$10.9 - $14.09 $76,300 - $98,630	7,000 Added 170.73%	11,100 $135,000
Q4 2018 Feb 11, 2019	BUY	$10.36 - $20.96 $42,476 - $85,936	4,100 New	4,100 $47,000
Q1 2018 May 11, 2018	SELL	$15.16 - $25.49 $93,992 - $158,038	-6,200 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$14.27 - $16.79 $2,854 - $3,358	-200 Reduced 3.13%	6,200 $94,000
Q3 2017 Nov 07, 2017	BUY	$10.77 - $22.1 $68,928 - $141,440	6,400	6,400 $101,000

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $8.17B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Intra Cellular Therapies, Inc. Transaction History